views
Abdulla A. Damluji, MD, PhD Profile picture
Mar 14 22 tweets 4 min read Read on X
Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Left Main Disease With or Without Diabetes: Findings From a Pooled Analysis of 4 Randomized Clinical Trials: @CircAHA

🥸wow: more on left main+diabetes: PCI vs CABG!

😱 Summary

👇👇👇 Image
1/ 🥸 Left main coronary artery disease and diabetes are associated with substantial cardiovascular morbidity and mortality.
2/ 🥸 Yet, long-term outcomes for patients with left main disease and diabetes undergoing PCI compared with CABG remain unclear.
3/ 🥸 Previous subgroup studies of individual randomized trials have attempted to address this issue but had limited power.
4/ 🥸 Moreover, registry-based studies have been constrained by biases and confounding.
5/🥸 Previous trials suggested that diabetes might modulate clinical outcomes, with a lower 5-year mortality rate in CABG patients but similar rates after PCI and CABG in non-diabetic patients.
6/ 🥸 The objective was to use pooled patient-level data from 4 major trials comparing PCI with CABG in patients with left main disease to examine outcomes in patients with versus without diabetes.
7/ 🥸 Data from SYNTAX, PRECOMBAT, NOBLE, and EXCEL trials were pooled and analyzed.

😱 Amazing!
8/ 🥸 Patients were categorized by the presence or absence of diabetes at baseline.
9/ 🥸 The primary endpoint was all-cause death through 5 years, with secondary endpoints including cardiovascular death, MI, stroke, and others.
10/ 🥸 Mortality rate at 10 years was also analyzed from 2 of the trials.
11/ 🥸 Statistical analysis involved comparing baseline characteristics and estimating time-to-event outcomes with Cox Proportional Hazards models.

🥸 Interactions between treatment effects and diabetes presence were evaluated for risk differences.
12/ 🥸 Exploratory analyses further stratified outcomes by diabetes treatment and compared event rates by treatment modality.

😱 The relationship between cardiovascular death and SYNTAX score in patients with and without diabetes was explored.
13/ 🥸 Among 4,394 patients with left main disease, nearly all had data on diabetes status, and showed 1,104 (25.1%) had diabetes, with 22.6% on insulin therapy.
14/ 🥸 Baseline characteristics, such as hypertension and dyslipidemia and multiple comorbidities, were more common in diabetic patients.

😱See table 👇
Image
Image
15/ 🥸 Diabetic patients experienced higher all-cause and cardiovascular death rates over 5 years compared to non-diabetics. Image
16/ 🥸 The risk remained even after adjusting for baseline differences, emphasizing the impact of diabetes on outcomes.
17/ 🥸 Despite diabetes, mortality rates after PCI and CABG were similar, with no significant difference observed

😱Look at this 👇👇👇
Image
Image
18/ 🥸 High SYNTAX scores in diabetics suggested an greater risk of cardiovascular death with PCI than CABG. Image
19/ 🥸 Across all patients, PCI was associated with lower early stroke risk but higher rates of MI and revascularization compared to CABG.
20/ 🥸 The findings highlight the need for a balanced discussion on revascularization strategies, especially in diabetic patients with left main disease.
21/ 🥸 This comprehensive analysis provides insights on shared decision-making in clinical practice, focusing on the trade-offs between PCI and CABG for left main disease +/- DM.

😱Excellent work...This needs an editorial @CircAHA

🥸 Have a nice day everyone!

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Abdulla A. Damluji, MD, PhD

Abdulla A. Damluji, MD, PhD Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @DrDamluji

Dec 3, 2023
Critical Care Management of Patients After Cardiac Arrest: A Scientific Statement From the American Heart Association and Neurocritical Care Society: @CircAHA

🥸Great work: @AHA_Research @AHA_AcuteCVCare

😱Let's summarize: Happy Sunday :)

👇👇👇 Image
1/🥸 Cardiac Arrest Prevalence: Over 600,000 individuals in the US experience cardiac arrest annually.

😱This is a significant public health problem.
2/ 🥸 Worldwide Incidence: Globally, cardiac arrest occurs in 30 to 97 individuals per 100,000 population.
Read 21 tweets
Nov 12, 2023
Great #AHA23 so far: @AHA_Research

🥸8 Trials: 8 take aways below

Read the read👇👇

1/ATRESIA:

Patients with subclinical atrial fibrillation can benefit from apixaban to reduce the risk of stroke and systemic thromboembolism. Image
2/CARDIA-SSBP:

🥸The decline in SBP with a low-sodium diet was independent of hypertension status and anti-hypertensive medication use, consistent across subgroups, and did not result in excess adverse Image
3/ CRHCP:

🥸Intensive BP lowering (target BP < 130/80 mm Hg) significantly reduced risk of all-cause dementia among patients with hypertension, supporting the use of intensive hypertension treatment to reduce the burden of dementia.

😱 @cardskrish Image
Read 11 tweets
Nov 11, 2023
Semaglutide and Cardiovascular Outcomes
in Obesity without Diabetes: @NEJM

The select trial: #AHA23

🥸Wow! @AHA_Research

😱Now on the stage in main event

😱Let's get the highlights

👇👇👇 Image
1.🥸 GLP-1 receptor agonists are known for cardiovascular benefits in type 2 diabetes.
2.🥸 The SELECT trial tested semaglutide, a potent member of GLP-1 class of drugs, for cardiovascular risk in overweight individuals without diabetes history.
Read 19 tweets
Oct 22, 2023
Frailty-Guided Management of Cardiovascular Disease— From Clinical Trials to Clinical Practice: @JAMACardio

🥸More on this in @JACCJournals soon...

Discussion below -

👇👇 Image
🥸1. Frailty is a reduced physiological reserve and increased vulnerability to stressors.

😱 Important for CVD Management and Interventional Cardiology Procedures.
🥸2. There's no single agreed-upon way to measure frailty.

😱 Annoying problem...
Read 28 tweets
Oct 8, 2023
Nondental Invasive Procedures and Risk of Infective Endocarditis: Time for a Revisit: A Science Advisory from the @American_Heart: @CircAHA

😱Can you please keep the summary less than 30 points?

🥸 I will try, but I do not want to.

😱🔫

Late Sunday summary below

👇👇👇 Image
1️⃣🥸😱 Infective endocarditis (IE) poses a risk of severe complications, and warrants prevention in high-risk patients.
2️⃣🥸😱 Prevention strategies historically focused on invasive dental procedures, with antibiotic prophylaxis (AP) used to prevent IE.
Read 32 tweets
Sep 18, 2023
Impact of Complete Revascularization in the ISCHEMIA Trial: @JACCJournals

How do you interpret the results of this ischemia sub-study? The devil is in the detail. 😱

Good morning: 🥸

Below 👇👇 Image
🥸1. In the ISCHEMIA study, 43.4% and 58.4% of revascularization procedures met the criteria for Achieved Complete Revascularization and Functional Complete Revascularization, respectively.
🥸2. For the entire cohort, these rates were almost the same, with 19.1% of patients only receiving medical treatment.
Read 36 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(